Aktie A0D9SD BIOTON S.A.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen BIOTON S.A.

Aktien

A0D9SD

PLBIOTN00029

BIO

Markt geschlossen - Warsaw S.E.
Andere Börsenplätze
 17:55:40 30.04.2024 		% 5 Tage % 1. Jan.
3,53 PLN +0,71 % Intraday Chart für BIOTON S.A. +0,28 % -1,12 %
28.03. BIOTON S.A. meldet Ergebnis für das Geschäftsjahr zum 31. Dezember 2023 CI
2023 BIOTON S.A. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
BIOTON S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
BIOTON S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
BIOTON S.A. Reports Earnings Results for the Half Year Ended June 30, 2023
BIOTON S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023
BIOTON S.A. Reports Earnings Results for the Full Year Ended December 31, 2022
BIOTON S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
BIOTON S.A. Reports Earnings Results for the Half Year Ended June 30, 2022
BIOTON S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022
BIOTON S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Bioton S.A. Reports Earnings Results for the Half Year Ended June 30, 2021
Brighter : Compatibility with New Insulins Opens Up New Market Opportunities for Brighter's Actiste
Bioton S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021
Yifan Pharmaceutical Co., Ltd. completed the acquisition of 19.79% stake in BIOTON S.A. from Ningbo Free Trade Zone Dongren Investment Co., Ltd.
Yifan Pharmaceutical Co., Ltd. completed the acquisition of 11.86% stake in BIOTON S.A. from Kelipond Investment Limited.
Yifan Pharmaceutical Co., Ltd. signed an agreement to acquire 11.86% stake in BIOTON S.A. from Kelipond Investment Limited for approximately CNY 270 million.
Yifan Pharmaceutical Co., Ltd. agreed to acquire 19.79% stake in BIOTON S.A. from Ningbo Free Trade Zone Dongren Investment Co., Ltd. for approximately CNY 450 million.
YiFan International Pharmaceutical Co., Limited completed the acquisition of SciGen Ltd from BIOTON S.A. and others.
YiFan International Pharmaceutical Co., Limited made a pre conditional offer to acquire SciGen Ltd from BIOTON S.A. and others for $28 million.
BIOTON Seeks Investor For SciGen Stake
Medwise Pharmaceuticals Limited completed the acquisition of Tricel S.A. from BIOTON S.A..
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0D9SD Aktie
  4. Nachrichten BIOTON S.A.
  5. Andere Sprachen